100
Participants
Start Date
November 30, 2021
Primary Completion Date
March 4, 2024
Study Completion Date
November 26, 2024
Iron Dextran
1000 mg IV
Erythropoietin (EPO)
40,000 units subcutaneous
Mayo Clinic in Rochester, Rochester
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Mayo Clinic
OTHER